Navigation Links
Settlement Announced in Medtronic Qui Tam Case
Date:12/12/2011

WASHINGTON, Dec. 12, 2011 /PRNewswire/ -- Medtronic, Inc, one of the world's largest medical device manufacturers, has agreed to a $23.5m settlement with the U.S. Department of Justice (DOJ), the Office of the Inspector General for the Department of Health and Human Services, and four relators in a qui tam suit related to cardiac rhythm management devices sold by Medtronic in the U.S., including pacemakers and implantable cardioverter defibrillators (ICDs).

The settlement ends a federal qui tam suit filed in Minnesota by Sanford Wittels & Heisler, as well as a similar qui tam suit filed in California. Both suits alleged Medtronic violated the U.S. False Claims Act by using post-market studies and device registries as vehicles to pay participating physicians kickbacks for implanting its pacemakers and ICDs in Medicare or Medicaid beneficiaries.

Under today's agreement, three relators will share a settlement of some $3.8 million. The fourth relator named in the settlement will receive $160,160.

David Sanford and Grant Morris of Sanford, Wittels & Heisler represents two of the relators in the Minnesota matter.

"Our society owes an enormous debt to individuals with the courage to blow the whistle when medical device makers try to influence physicians," said Mr. Sanford. "When the use of procedures or devices is driven by corporate greed rather than medical need, it creates a potentially dangerous situation for patients and contributes to escalating medical costs."

The qui tam or whistle blower provisions of the False Claims Act permit private citizens, called "relators," to bring lawsuits on behalf of the United States and receive a portion of proceeds of any settlement or judgment. 

Mr. Morris added, "We are pleased to play a role in shining a light into this dark corner of medical device marketing. Medtronic has done the right thing by settling this matter."

Medtronic simultaneously entered into separate settlement agreements with certain states and the District of Columbia based on allegations that the company used its post-market studies and physician registries to promote the submission of similar false claims under those states' Medicaid programs.

About SWH

Sanford Wittels & Heisler is a law firm with offices in Washington, D.C., New York, and San Francisco that specializes in qui tam, employment discrimination, wage and hour, consumer and complex corporate class action litigation and has represented thousands of individuals in major class action cases in the United States. The firm also represents individual clients in employment, employment discrimination, sexual harassment, whistleblower, public accommodations, commercial, medical malpractice, and personal injury matters. In May 2010, the firm secured the largest jury award in the U.S. in a gender discrimination class action in an employment case when a jury returned a verdict of $253 million in compensatory and punitive damages against Novartis Pharmaceuticals Corporation.  For more information, contact Sanford Wittels & Heisler at (202) 742-7777.


'/>"/>
SOURCE Sanford Wittels & Heisler LLP
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. K-V Pharmaceutical Company Comments on Recent Settlement With the Department of Justice
2. Kahn Swick & Foti, LLC Announces Class Action Settlement on Behalf of Purchasers of Publicly-Traded Securities of Acura Pharmaceuticals, Inc. -- ACUR
3. Mylan Announces Settlement Agreement for its First-to-File Generic Version of Vivelle-Dot®
4. Kremers Urban Pharmaceuticals Inc. Announces Lipitor® Settlement Agreement
5. Mylan Announces Femcon® Fe Settlement Agreement
6. Mylan Announces XELODA® Settlement and License Agreement
7. Misonix Announces Settlement of PuriCore Litigation, Including Entry into a U.S. Distribution Agreement for PuriCores Advanced Wound Care Product
8. Breckenridge Pharmaceutical Announces Settlement of Actos® (Pioglitazone Hydrochloride) Patent Litigation
9. Perrigo Announces Settlement of Cutivate Lotion Litigation
10. Par Pharmaceutical Companies Announces Settlement in Principle Regarding Certain Drug Pricing Lawsuits
11. Johnson & Johnson Announces Settlement With U.S. Department of Justice and U.S. Securities and Exchange Commission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and Company ... results for the third quarter of 2017 on Tuesday, ... call on that day with the investment community and ... The conference call will begin at 9 a.m. ... access a live webcast of the conference call through ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many ... event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids ... of all ages; it is a non-competitive, non-timed event, which is all about having ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... for healthcare compliance program management, will showcase a range of technology and learning ... Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 at ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a ... health care, have expanded their existing home health joint venture through an agreement, ... been operating a joint venture home health company with Asante, delivering clinically integrated ...
Breaking Medicine News(10 mins):